Insights into Mechanism of Glucokinase Activation

Background: Human glucokinase (GK) is a principal regulator of glucose homeostasis. Results: The structure of the catalytic complex of GK has been determined, and multiple conformations have been directly observed in solution. Conclusion: In solution, glucose dose-dependently converts GK from the apo conformation to an active open conformation. Significance: Understanding the conformational changes of GK during the reaction is crucial for designing better glucokinase activators with safer profiles. Human glucokinase (GK) is a principal regulating sensor of plasma glucose levels. Mutations that inactivate GK are linked to diabetes, and mutations that activate it are associated with hypoglycemia. Unique kinetic properties equip GK for its regulatory role: although it has weak basal affinity for glucose, positive cooperativity in its binding of glucose causes a rapid increase in catalytic activity when plasma glucose concentrations rise above euglycemic levels. In clinical trials, small molecule GK activators (GKAs) have been efficacious in lowering plasma glucose and enhancing glucose-stimulated insulin secretion, but they carry a risk of overly activating GK and causing hypoglycemia. The theoretical models proposed to date attribute the positive cooperativity of GK to the existence of distinct protein conformations that interconvert slowly and exhibit different affinities for glucose. Here we report the respective crystal structures of the catalytic complex of GK and of a GK-glucose complex in a wide open conformation. To assess conformations of GK in solution, we also carried out small angle x-ray scattering experiments. The results showed that glucose dose-dependently converts GK from an apo conformation to an active open conformation. Compared with wild type GK, activating mutants required notably lower concentrations of glucose to be converted to the active open conformation. GKAs decreased the level of glucose required for GK activation, and different compounds demonstrated distinct activation profiles. These results lead us to propose a modified mnemonic model to explain cooperativity in GK. Our findings may offer new approaches for designing GKAs with reduced hypoglycemic risk.

[1]  Jing Chen,et al.  Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. , 2012, Journal of medicinal chemistry.

[2]  R. Vincentelli,et al.  The active conformation of human glucokinase is not altered by allosteric activators. , 2011, Acta crystallographica. Section D, Biological crystallography.

[3]  M. Ammirati,et al.  Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus , 2011 .

[4]  P. Njølstad,et al.  Binding of ATP at the active site of human pancreatic glucokinase – nucleotide-induced conformational changes with possible implications for its kinetic cooperativity , 2011, The FEBS journal.

[5]  Clemens Vonrhein,et al.  Data processing and analysis with the autoPROC toolbox , 2011, Acta crystallographica. Section D, Biological crystallography.

[6]  M. Larion,et al.  Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase. , 2010, Biochemistry.

[7]  R. Brüschweiler,et al.  Direct evidence of conformational heterogeneity in human pancreatic glucokinase from high-resolution nuclear magnetic resonance. , 2010, Biochemistry.

[8]  Jill Trewhella,et al.  Small‐angle scattering for structural biology—Expanding the frontier while avoiding the pitfalls , 2010, Protein science : a publication of the Protein Society.

[9]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[10]  J. Zorn,et al.  Turning enzymes ON with small molecules. , 2010, Nature chemical biology.

[11]  A. Duttaroy,et al.  Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes. , 2009, Journal of medicinal chemistry.

[12]  G. Ferry,et al.  Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states. , 2009, Biochemistry.

[13]  Friedrich Förster,et al.  Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90. , 2008, Structure.

[14]  Greg L. Hura,et al.  X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. , 2011, Quarterly reviews of biophysics.

[15]  John A. Tainer,et al.  X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution , 2007, Quarterly Reviews of Biophysics.

[16]  Shaoxian Sun,et al.  Biochemical Basis of Glucokinase Activation and the Regulation by Glucokinase Regulatory Protein in Naturally Occurring Mutations* , 2006, Journal of Biological Chemistry.

[17]  A. Kadotani,et al.  An Allosteric Activator of Glucokinase Impairs the Interaction of Glucokinase and Glucokinase Regulatory Protein and Regulates Glucose Metabolism* , 2006, Journal of Biological Chemistry.

[18]  D. Nettleton,et al.  Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. , 2006, Biochemistry.

[19]  J. Gromada,et al.  A novel glucokinase activator modulates pancreatic islet and hepatocyte function. , 2005, Endocrinology.

[20]  F. Matschinsky Glucokinase, glucose homeostasis, and diabetes mellitus , 2005, Current diabetes reports.

[21]  M. Magnuson,et al.  Glucokinase as a Glucose Sensor: Past, Present and Future , 2004 .

[22]  U. Kammlott,et al.  Crystal Structure of Human Liver Glucokinase Bound to a Small Molecule Allosteric Activator , 2004 .

[23]  H. Huopio,et al.  Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. , 2004, Diabetes.

[24]  M. Magnuson,et al.  Glucokinase and glycemic disease: from basics to novel therapeutics. , 2004 .

[25]  Teruyuki Nishimura,et al.  Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. , 2004, Structure.

[26]  M. Ravier,et al.  Hierarchy of the β‐cell signals controlling insulin secretion , 2003, European journal of clinical investigation.

[27]  A. Hattersley,et al.  Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. , 2003, Diabetes.

[28]  J. Grippo,et al.  Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy , 2003, Science.

[29]  I. Weber,et al.  Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia. , 1999, Diabetes.

[30]  H. Fromm,et al.  Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. , 1998, Journal of molecular biology.

[31]  F M Matschinsky,et al.  Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.

[32]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[33]  G. Kleywegt,et al.  Detecting folding motifs and similarities in protein structures. , 1997, Methods in enzymology.

[34]  D. Svergun,et al.  CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .

[35]  E. Van Schaftingen,et al.  Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  M. Magnuson,et al.  Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. , 1994, The Journal of biological chemistry.

[37]  A. Hattersley,et al.  Linkage of type 2 diabetes to the glucokinase gene , 1992, The Lancet.

[38]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[39]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[40]  K. Neet,et al.  Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy. , 1990, The Journal of biological chemistry.

[41]  P. Iynedjian,et al.  Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. , 1988, The Journal of biological chemistry.

[42]  D. I. Svergun,et al.  Structure Analysis by Small-Angle X-Ray and Neutron Scattering , 1987 .

[43]  T. Steitz,et al.  Structural dynamics of yeast hexokinase during catalysis. , 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[44]  J. Ricard,et al.  Enzyme memory. 2. Kinetics and thermodynamics of the slow conformation changes of wheat-germ hexokinase LI. , 1977, European Journal of Biochemistry.

[45]  I. H. Segel Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[46]  J. Ricard,et al.  Regulatory Behavior of Monomeric Enzymes , 1974 .

[47]  J. Ricard,et al.  Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept. , 1974, European journal of biochemistry.

[48]  K. Neet,et al.  Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes. , 1972, The Journal of biological chemistry.